RIO DE JANEIRO, BRAZIL - Pfizer announced on Wednesday that it would request approval for the use of the Comirnaty vaccine against Covid-19 in children aged 5 to 11 years in Brazil. The request will be sent to the national health regulatory agency (ANVISA) next month. The date, however, has not yet been set.
"The submission of the request to ANVISA for the approval of the use of the ComiRNAty vaccine, from Pfizer/BioNTech, for children between 5 and 11 years old should occur throughout November 2021," the note says.
The request followstaht sent to the Food and Drug Administration . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here